Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens.

Bibliographic Details
Main Author: Colin Sutherland
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2007-05-01
Series:PLoS Medicine
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1880847/?tool=EBI
_version_ 1819160649926705152
author Colin Sutherland
author_facet Colin Sutherland
author_sort Colin Sutherland
collection DOAJ
first_indexed 2024-12-22T16:59:49Z
format Article
id doaj.art-1005dd8f4bee432187b62117bc9486e5
institution Directory Open Access Journal
issn 1549-1277
1549-1676
language English
last_indexed 2024-12-22T16:59:49Z
publishDate 2007-05-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Medicine
spelling doaj.art-1005dd8f4bee432187b62117bc9486e52022-12-21T18:19:22ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762007-05-014510.1371/journal.pmed.0040175Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens.Colin Sutherlandhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1880847/?tool=EBI
spellingShingle Colin Sutherland
Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens.
PLoS Medicine
title Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens.
title_full Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens.
title_fullStr Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens.
title_full_unstemmed Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens.
title_short Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens.
title_sort correction a challenge for the development of malaria vaccines polymorphic target antigens
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1880847/?tool=EBI
work_keys_str_mv AT colinsutherland correctionachallengeforthedevelopmentofmalariavaccinespolymorphictargetantigens